X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ASTRAZENECA PHARMA Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Quarterly Results   (AIDL)

Here are the latest quarterly results of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA financial fact sheet and ASTRAZENECA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

ASTRAZENECA PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,3201,2841,4461,5881,3951,3821,5031,116 
Other income Rs m1715152116189864 
Turnover Rs m1,3371,2981,4611,6091,4111,4001,6011,180 
Expenses Rs m1,2671,3211,3291,5561,2361,3491,3531,163 
Gross profit Rs m53-371163216032149-47 
Depreciation Rs m4345444241414037 
Interest Rs m00000000 
Profit before tax Rs m27-67871113510208-20 
Tax Rs m0005292489 
Profit after tax Rs m27-678761068160-29 
Gross profit margin %4.0-2.98.12.011.42.39.9-4.3 
Effective tax rate %0.00.00.047.621.519.423.1-44.4 
Net profit margin %2.1-5.26.00.47.60.610.6-2.6 
Diluted EPS Rs 1.1 -2.7 3.5 0.2 4.2 0.3 6.4 -1.2  
Diluted EPS (TTM) Rs -0.2 8.3 17.1 2.1 5.2 8.2 11.2 9.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   AMAR REMEDIES  ALEMBIC LTD  SUN PHARMA  DIVIS LABORATORIES  AJANTA PHARMA  

Compare ASTRAZENECA PHARMA With:   AMAR REMEDIES  ALEMBIC LTD  SUN PHARMA  DIVIS LABORATORIES  AJANTA PHARMA  

Compare ASTRAZENECA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Erases Gains; Telecom Stocks Plunge as RIL Unveils JioPhone(01:30 pm)

After opening the day marginally higher, the share markets in India are currently trading below the dotted line. Sectoral indices are trading mixed with stocks in the information technology sector.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

Warren Buffett's Long Term Returns Immune to Volatility(Chart Of The Day)

Jul 8, 2017

Buffett's periodic underperformance to index fund.

More

ASTRAZENECA PHARMA SHARE PRICE


Jul 21, 2017 02:15 PM

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - TEVA PHARMA COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS